172 related articles for article (PubMed ID: 27840956)
21. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.
Skrzypek K; Kusienicka A; Szewczyk B; Adamus T; Lukasiewicz E; Miekus K; Majka M
Oncotarget; 2015 Oct; 6(31):31378-98. PubMed ID: 26384300
[TBL] [Abstract][Full Text] [Related]
22. RasGRF1 regulates proliferation and metastatic behavior of human alveolar rhabdomyosarcomas.
Tarnowski M; Schneider G; Amann G; Clark G; Houghton P; Barr FG; Kenner L; Ratajczak MZ; Kucia M
Int J Oncol; 2012 Sep; 41(3):995-1004. PubMed ID: 22752028
[TBL] [Abstract][Full Text] [Related]
23. Hepatocyte growth factor exerts multiple biological functions on bovine mammary epithelial cells.
Accornero P; Martignani E; Macchi E; Baratta M
J Dairy Sci; 2007 Sep; 90(9):4289-96. PubMed ID: 17699048
[TBL] [Abstract][Full Text] [Related]
24. RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo.
Bessard A; Frémin C; Ezan F; Fautrel A; Gailhouste L; Baffet G
Oncogene; 2008 Sep; 27(40):5315-25. PubMed ID: 18521085
[TBL] [Abstract][Full Text] [Related]
25. Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A.
Cacci E; Salani M; Anastasi S; Perroteau I; Poiana G; Biagioni S; Augusti-Tocco G
J Neurosci Res; 2003 Dec; 74(5):760-8. PubMed ID: 14635227
[TBL] [Abstract][Full Text] [Related]
26. PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells.
Crosswell HE; Dasgupta A; Alvarado CS; Watt T; Christensen JG; De P; Durden DL; Findley HW
BMC Cancer; 2009 Nov; 9():411. PubMed ID: 19939254
[TBL] [Abstract][Full Text] [Related]
27. BMS-777607, a small-molecule met kinase inhibitor, suppresses hepatocyte growth factor-stimulated prostate cancer metastatic phenotype in vitro.
Dai Y; Siemann DW
Mol Cancer Ther; 2010 Jun; 9(6):1554-61. PubMed ID: 20515943
[TBL] [Abstract][Full Text] [Related]
28. Homeobox gene HLX is a regulator of HGF/c-met-mediated migration of human trophoblast-derived cell lines.
Rajaraman G; Murthi P; Brennecke SP; Kalionis B
Biol Reprod; 2010 Oct; 83(4):676-83. PubMed ID: 20554918
[TBL] [Abstract][Full Text] [Related]
29. Erk2 but not Erk1 regulates crosstalk between Met and EGFR in squamous cell carcinoma cell lines.
Gusenbauer S; Zanucco E; Knyazev P; Ullrich A
Mol Cancer; 2015 Mar; 14():54. PubMed ID: 25884419
[TBL] [Abstract][Full Text] [Related]
30. Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing.
Xu KP; Yu FS
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2242-8. PubMed ID: 17460286
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
[TBL] [Abstract][Full Text] [Related]
32. HGF derived from cancer‑associated fibroblasts promotes vascularization in gastric cancer via PI3K/AKT and ERK1/2 signaling.
Ding X; Xi W; Ji J; Cai Q; Jiang J; Shi M; Yu Y; Zhu Z; Zhang J
Oncol Rep; 2018 Aug; 40(2):1185-1195. PubMed ID: 29917165
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
[TBL] [Abstract][Full Text] [Related]
34. Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment.
Slørdahl TS; Denayer T; Moen SH; Standal T; Børset M; Ververken C; Rø TB
Eur J Haematol; 2013 Nov; 91(5):399-410. PubMed ID: 23952536
[TBL] [Abstract][Full Text] [Related]
35. Role of the MET/HGF receptor in proliferation and invasive behavior of osteosarcoma.
Coltella N; Manara MC; Cerisano V; Trusolino L; Di Renzo MF; Scotlandi K; Ferracini R
FASEB J; 2003 Jun; 17(9):1162-4. PubMed ID: 12709413
[TBL] [Abstract][Full Text] [Related]
36. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
[TBL] [Abstract][Full Text] [Related]
37. The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma.
Derksen PW; de Gorter DJ; Meijer HP; Bende RJ; van Dijk M; Lokhorst HM; Bloem AC; Spaargaren M; Pals ST
Leukemia; 2003 Apr; 17(4):764-74. PubMed ID: 12682635
[TBL] [Abstract][Full Text] [Related]
38. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines.
Kouraklis G; Triche TJ; Wesley R; Tsokos M
Pediatr Res; 1999 Apr; 45(4 Pt 1):552-8. PubMed ID: 10203148
[TBL] [Abstract][Full Text] [Related]
39. Hepatocyte growth factor promotes colonic epithelial regeneration via Akt signaling.
Kanayama M; Takahara T; Yata Y; Xue F; Shinno E; Nonome K; Kudo H; Kawai K; Kudo T; Tabuchi Y; Watanabe A; Sugiyama T
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G230-9. PubMed ID: 17412827
[TBL] [Abstract][Full Text] [Related]
40. Migration induced by epidermal and hepatocyte growth factors in oral squamous carcinoma cells in vitro: role of MEK/ERK, p38 and PI-3 kinase/Akt.
Brusevold IJ; Aasrum M; Bryne M; Christoffersen T
J Oral Pathol Med; 2012 Aug; 41(7):547-58. PubMed ID: 22413835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
